Skip to content

Pilot study of the robot-assisted therapy of hand proprioception after stroke

Pilot study of the robot-assisted therapy of hand proprioception after stroke - ETH MIKE Therapy

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027932
Enrollment
10
Registered
2022-02-04
Start date
2022-01-31
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I64

Interventions

Group 1: Arm 1: Stroke survivors (sub-acute) Ten patients will be assessed at inclusion using the robotic as well as the clinical assessments. Then, for 3 weeks they will perform exercises with the

Sponsors

Kliniken Schmieder Allensbach
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosis of stroke (ischemic or hemorrhagic) 2. Subacute stroke at study inclusion (< 3 months since stroke at first measurement) 3. Sufficient cognitive function to understand task instructions (as assessed by the recruiting physiotherapist) 4. No pain when inserting the index finger in the robotic device 5. Minimum passive range of motion of the index finger (30 degrees) 6. No strong spasticity (Modified Ashworth Scale <= 3)

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Robotic metrics. What and how: index finger proprioception, range of motion, force, tracing smoothness - metrics extracted from the robotic device ETH MIKE (as described here: https://jneuroengrehab.biomedcentral.com/articles/10.1186/s12984-021-00904-5) When: at inclusion and after 3 weeks of intervention (at discharge)

Secondary

MeasureTime frame
Clinical outcomes: Box & Block test, Nottingham Sensory Assessment (proprioception of index finger only), Montreal Cognitive Assessment, Neglect Assessment (Bell Test); Test of Attentional Performance (TAP). Collected at inclusion and at discharge (after 3 weeks of intervention). Usability outcomes: NASA TLX, Likert scale (questionnaires). Study drop-out rate, report of adverse events.

Countries

Germany

Contacts

Public ContactMonika Zbytniewska

ETH Zürich

monika.zbytniewska@hest.ethz.ch+41779615277

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026